These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7513778)

  • 1. Possible toxicity with the association of G-CSF and bleomycin.
    Bastion Y; Reyes F; Bosly A; Gisselbrecht C; Yver A; Gilles E; Maral J; Coiffier B
    Lancet; 1994 May; 343(8907):1221-2. PubMed ID: 7513778
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary toxicity of bleomycin: is G-CSF a risk factor?
    Bastion Y; Coiffier B
    Lancet; 1994 Aug; 344(8920):474. PubMed ID: 7520108
    [No Abstract]   [Full Text] [Related]  

  • 3. Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma.
    Lei KI; Leung WT; Johnson PJ
    Br J Cancer; 1994 Nov; 70(5):1009-13. PubMed ID: 7524599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma.
    Yokose N; Ogata K; Tamura H; An E; Nakamura K; Kamikubo K; Kudoh S; Dan K; Nomura T
    Br J Cancer; 1998 Jun; 77(12):2286-90. PubMed ID: 9649147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor
    Andersen MD; Kamper P; d'Amore A; Clausen M; Bentzen H; d'Amore F
    Leuk Lymphoma; 2019 Apr; 60(4):927-933. PubMed ID: 30277120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia.
    Ho P; Sherman P; Grigg A
    Eur J Haematol; 2012 May; 88(5):416-21. PubMed ID: 22296221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary toxicity during granulocyte colony stimulating factor administration and neutrophils.
    Katoh M; Takada M; Nakayama M; Umeda M
    Chest; 1996 Aug; 110(2):576-7. PubMed ID: 8697875
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary toxicity in patients with advanced-stage germ cell tumors receiving bleomycin with and without granulocyte colony stimulating factor.
    Saxman SB; Nichols CR; Einhorn LH
    Chest; 1997 Mar; 111(3):657-60. PubMed ID: 9118704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
    Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy.
    Zagonel V; Babare R; Merola MC; Talamini R; Lazzarini R; Tirelli U; Carbone A; Monfardini S
    Ann Oncol; 1994; 5 Suppl 2():127-32. PubMed ID: 7515645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of granulocyte colony-stimulating factor on experimental bleomycin-induced pulmonary fibrosis].
    Skurikhin EG; Andreeva TV; Khmelevskaia ES; Ermolaeva LA; Pershina OV; Ermakova NN; Stepanova IE; Reztsova AM; Krupin VA; Gol'dberg VE; Reĭkhart DV; Dygaĭ AM
    Eksp Klin Farmakol; 2012; 75(1):30-3. PubMed ID: 22442961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of cardiac toxicity by 123I-MIBG myocardial SPECT in elderly non-Hodgkin lymphoma patients treated with COP-BLAM and G-CSF].
    Niitsu N; Umeda M
    Rinsho Ketsueki; 1995 Nov; 36(11):1326-8. PubMed ID: 8691577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Focus on granulocyte colony-stimulating factor-induced pulmonary toxicity].
    Noël-Savina E; Descourt R
    Bull Cancer; 2012 Feb; 99(2):211-7. PubMed ID: 22265942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.
    Ballestrero A; Ferrando F; Garuti A; Basta P; Gonella R; Stura P; Mela GS; Sessarego M; Gobbi M; Patrone F
    J Clin Oncol; 1999 Apr; 17(4):1296. PubMed ID: 10561192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy.
    Avilés A; Díaz-Maqueo JC; Talavera A; Nambo MJ; García EL
    Leuk Lymphoma; 1994 Sep; 15(1-2):153-7. PubMed ID: 7532056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony stimulating factor (G-CSF) as adjunct therapy in relapsed-resistant high-grade non-Hodgkin's lymphoma.
    Zinzani PL; Martelli M; Tura S; Mandelli F
    Haematologica; 1993; 78(1):40-3. PubMed ID: 7684011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
    Rossi G; Donisi A; Casari S; Re A; Stellini R; Cadeo G; Carosi G
    Haematologica; 1998 Apr; 83(4):317-22. PubMed ID: 9592981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of chemotherapy-induced neutropenia using G-CSF with VACOP-B--a case report.
    Anglin P; Strauss BA; Brandwein JM
    Leuk Lymphoma; 1993 Nov; 11(5-6):469-72. PubMed ID: 7510192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
    Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
    J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial pneumonitis related to granulocyte colony-stimulating factor administration following chemotherapy for elderly patients with non-Hodgkin's lymphoma.
    Hasegawa Y; Ninomiya H; Kamoshita M; Ohtani K; Kobayashi T; Kojima H; Nagasawa T; Abe T
    Intern Med; 1997 May; 36(5):360-4. PubMed ID: 9213175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.